2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Debility in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bukovac, S; Green, MR; Guerin, C; Isedowo, R; Lillie, L; McCormick, CM; Nar, NN; Said, SA; Simone, JJ; Stuart, JA | 1 |
1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Debility
Article | Year |
---|---|
Effects of long-term dietary administration of estrogen receptor-beta agonist diarylpropionitrile on ovariectomized female ICR (CD-1) mice.
Topics: Aging; Animals; Behavior, Animal; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogen Receptor beta; Female; Frailty; Mice; Mice, Inbred ICR; Nitriles; Ovariectomy; Propionates; Random Allocation; Reference Values | 2018 |